ES2180629T3 - Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad. - Google Patents

Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad.

Info

Publication number
ES2180629T3
ES2180629T3 ES95913668T ES95913668T ES2180629T3 ES 2180629 T3 ES2180629 T3 ES 2180629T3 ES 95913668 T ES95913668 T ES 95913668T ES 95913668 T ES95913668 T ES 95913668T ES 2180629 T3 ES2180629 T3 ES 2180629T3
Authority
ES
Spain
Prior art keywords
protein
therapeutic uses
bactericide
permeability increased
bpi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95913668T
Other languages
English (en)
Inventor
William Steve Ammons
Roger G Little
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Technology Ltd USA
Original Assignee
Xoma Technology Ltd USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd USA filed Critical Xoma Technology Ltd USA
Application granted granted Critical
Publication of ES2180629T3 publication Critical patent/ES2180629T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

COMPOSICIONES TERAPEUTICAS MEJORADAS, METODOS Y USOS DE PRODUCTOS DE PROTEINAS BACTERICIDAS O QUE AUMENTAN LA PERMEABILIDAD (BPI) QUE CONLLEVAN EL USO DE FORMAS DIMERICAS DE PRODUCTOS MONOMERICOS DE PROTEINAS (BPI) CARACTERIZADOS POR UNA ACTIVIDAD BIOLOGICA IN VIVO MEJORADA. LAS FORMULACIONES PREFERENTES INCLUYEN 50% O MAS, POR PESO, DEL PRODUCTO DIMERICO Y LOS USOS TERAPEUTICOS PREFERENTES INCLUYEN LA NEUTRALIZACION DE HEPARINA Y DE ENDOTOXINAS.
ES95913668T 1994-03-11 1995-03-13 Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad. Expired - Lifetime ES2180629T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/212,132 US5447913A (en) 1994-03-11 1994-03-11 Therapeutic uses of bactericidal/permeability-increasing protein dimer products

Publications (1)

Publication Number Publication Date
ES2180629T3 true ES2180629T3 (es) 2003-02-16

Family

ID=22789691

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95913668T Expired - Lifetime ES2180629T3 (es) 1994-03-11 1995-03-13 Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad.

Country Status (12)

Country Link
US (4) US5447913A (es)
EP (1) EP0749317B1 (es)
JP (1) JPH09510217A (es)
AT (1) ATE218879T1 (es)
AU (1) AU703134B2 (es)
CA (1) CA2185155C (es)
DE (1) DE69527049T2 (es)
DK (1) DK0749317T3 (es)
ES (1) ES2180629T3 (es)
HK (1) HK1014159A1 (es)
PT (1) PT749317E (es)
WO (1) WO1995024209A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU703211B2 (en) * 1994-01-14 1999-03-18 Xoma Corporation Anti-fungal methods and materials
US5447913A (en) 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
AU730307B2 (en) * 1995-11-14 2001-03-01 Xoma Corporation Bactericidal permeability increasing protein (BPI) for treating conditions associated with corneal injury
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
EP0914144B1 (en) * 1996-05-10 2000-12-13 XOMA Technology Ltd. Therapeutic uses of bpi protein products for human meningococcemia
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
US5945399A (en) * 1996-05-23 1999-08-31 Xoma Corporation Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
WO1997044354A2 (en) * 1996-05-24 1997-11-27 Regents Of The University Of Minnesota Synthesis of soluble beta-sheet forming peptides
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
JP2002509527A (ja) * 1996-11-01 2002-03-26 ゾーマ コーポレイション 嚢胞性線維症におけるｂｐｉタンパク質産物の治療用途
US6482796B2 (en) * 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US20050159343A1 (en) * 1999-03-26 2005-07-21 Board Of Regents, University Of Texas System Inhibitors of glycosaminoglycans
WO2001003724A1 (en) * 1999-07-12 2001-01-18 Xoma Technology Ltd. Therapeutic uses of bpi protein products for inhibiting h+/k+ atpase activity
CA2397835A1 (en) * 2000-01-20 2001-07-26 Regents Of The University Of Minnesota Polypeptides with therapeutic activity and methods of use
US6686180B2 (en) * 2000-04-04 2004-02-03 Baxter International Inc. Method for the production of bacterial toxins
US20020173464A1 (en) * 2000-12-01 2002-11-21 King George L. Modulation of pericyte proliferation
EP1572719A4 (en) 2002-02-20 2007-11-14 Univ Minnesota PARTIAL PEPTIDE MIMETICS AND METHOD
DE60335794D1 (de) 2002-03-29 2011-03-03 Xoma Technology Ltd Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden
US20040037895A1 (en) * 2002-08-23 2004-02-26 Alex Zhu Methods of treating involuntary facial spasms and facial wrinkles
EP1741440A1 (en) 2005-07-08 2007-01-10 Mellitus S.L. Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders
KR101367479B1 (ko) * 2008-07-21 2014-03-14 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
CN117686438A (zh) * 2024-02-02 2024-03-12 东北大学秦皇岛分校 一种基于红外偏振光的远程材料鉴别方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5089274A (en) * 1989-02-14 1992-02-18 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
WO1993023434A2 (en) * 1992-05-19 1993-11-25 Xoma Corporation Bpi-immunoglobulin fusion proteins
ATE178652T1 (de) * 1992-05-19 1999-04-15 Xoma Corp Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
CA2155005C (en) * 1993-02-02 1999-04-06 Weldon Courtney Mcgregor Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US5348942A (en) * 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
ATE169304T1 (de) * 1993-03-12 1998-08-15 Xoma Corp Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
AU6361894A (en) * 1993-03-12 1994-09-26 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
ATE202482T1 (de) * 1993-03-12 2001-07-15 Xoma Technology Ltd Therapeutische verwendungen von antibakteriellen/durchlässigkeitserhöhenden proteinprodukten
AU7330994A (en) * 1993-07-14 1995-02-13 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
NZ275205A (en) * 1993-09-22 1998-03-25 Xoma Corp Use of bactericidal/permeability-increasing protein in treating gram-negative bacterial infection
CA2173611C (en) * 1993-10-05 2005-07-26 Paul A. M. Van Leeuwen Method of treating depressed reticuloendothelial system function
AU703211B2 (en) * 1994-01-14 1999-03-18 Xoma Corporation Anti-fungal methods and materials
PT754050E (pt) * 1994-01-14 2002-11-29 Xoma Technology Ltd Metodos e materiais contra bacterias gram-positivas
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US5494896A (en) * 1995-03-31 1996-02-27 Xoma Corporation Method of treating conditions associated with burn injuries

Also Published As

Publication number Publication date
DE69527049D1 (de) 2002-07-18
US5703038A (en) 1997-12-30
US5447913A (en) 1995-09-05
JPH09510217A (ja) 1997-10-14
AU1996995A (en) 1995-09-25
ATE218879T1 (de) 2002-06-15
DE69527049T2 (de) 2003-03-06
CA2185155A1 (en) 1995-09-14
US5856302A (en) 1999-01-05
WO1995024209A1 (en) 1995-09-14
EP0749317B1 (en) 2002-06-12
PT749317E (pt) 2002-11-29
DK0749317T3 (da) 2002-10-07
US6277821B1 (en) 2001-08-21
AU703134B2 (en) 1999-03-18
HK1014159A1 (en) 1999-09-24
CA2185155C (en) 2001-08-14
EP0749317A1 (en) 1996-12-27

Similar Documents

Publication Publication Date Title
ES2180629T3 (es) Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad.
EE9400356A (et) Polüetüleenglükool proteiin konjugaadid, ühendid, nende kasutamine, meetod konjugaatide valmistamiseks ja ravimvormid
ATE186212T1 (de) Geschmacksmaskierte pharmazeutische mittel
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
FR13C0021I2 (fr) Conjugates d'exendin-4 et leur utilisation medicale
SE9804614D0 (sv) New peptides and use thereof
RU95106680A (ru) Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции
ES2184901T3 (es) Anticuerpos anti-idiotipicos del factor de crecimiento endotelial vascular y su utilizacion como medicamentos.
TR200100637T2 (tr) Yeni doğal ürün türevleri
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
MX9805065A (es) Nuevos derivados bi-aromaticos del dibenzofurano y su utilizacion en medicina humana o veterinaria asi como en cosmetica.
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
IT216694Z2 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
DE69208865T2 (de) Haarpflegemittel
DE69323191D1 (de) Wasserlösliche retinoide
ES2176955T3 (es) Productos cosmeticos o dermo-farmaceuticos que respetan la ecologia cutanea.
ITCB950001A0 (it) Deamarizzazione delle olive da tavola per via microbiologica, mediantel'impiego di microorganismi oleuropeinolitici selezionati
ZA925784B (en) Polypeptides capable of inducing antibodies in vivo themselves capable of inhibiting the invasion of red blood cells by merozoites of P. falciparum, related products and their use in the production of vaccine compositions.
ITRM940453A0 (it) "uso della proteina p1lsa per la preparazione di un medicamento da utilizzarsi nella terapia di patologie indotte da danni cellulari da agenti fisici, chimici o biologici"